1. Home
  2. EML vs LIXT Comparison

EML vs LIXT Comparison

Compare EML & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern Company (The)

EML

Eastern Company (The)

HOLD

Current Price

$25.32

Market Cap

129.1M

ML Signal

HOLD

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$7.21

Market Cap

107.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EML
LIXT
Founded
1858
2005
Country
United States
United States
Employees
N/A
3
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.1M
107.6M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
EML
LIXT
Price
$25.32
$7.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
59.6K
594.5K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
1.98%
N/A
EPS Growth
185.40
N/A
EPS
0.11
N/A
Revenue
$248,970,345.00
N/A
Revenue This Year
$19.05
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$235.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$2.45
52 Week High
$29.91
$8.38

Technical Indicators

Market Signals
Indicator
EML
LIXT
Relative Strength Index (RSI) 54.61 54.53
Support Level $18.34 $6.21
Resistance Level $29.91 $7.64
Average True Range (ATR) 1.39 0.84
MACD -0.06 -0.05
Stochastic Oscillator 37.81 53.35

Price Performance

Historical Comparison
EML
LIXT

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The company's drug product pipeline is focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. Its product is LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company operates in a single reportable segment, which consists of the development of cancer treatments.

Share on Social Networks: